GIFLF:OTCMKTS
Grifols SA Class A
US$11,13
0,00%
(0,00) 1D
15 ກ.ຍ., 15 ໂມງ 11 ນາທີ 14 ວິນາທີ GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GIFLF...
Mkt. cap
6,60 ຕື້
Avg. vol.
543,00
Volume
0,00
52-wk high
US$12,90
52-wk low
US$10,13
Beta
0,90
Shares outstanding
426,13 ລ້ານ
No. of employees
25 ພັນ
Mkt. cap
6,60 ຕື້
Avg. vol.
543,00
Volume
0,00
52-wk high
US$12,90
52-wk low
US$10,13
Beta
0,90
Shares outstanding
426,13 ລ້ານ
No. of employees
25 ພັນ
News stories
From web sources and news partners
AD HOC NEWS
·
11 ຊົ່ວໂມງກ່ອນ
Grifols stock was upgraded as first-half profit rose
AD HOC NEWS
·
15 ຊົ່ວໂມງກ່ອນ
Grifols stock pre-market: EUR 9.84, prior close EUR 9.87
Yahoo Finance
·
1 ມື້ກ່ອນ
Are Options Traders Betting on a Big Move in Grifols Stock?
AD HOC NEWS
·
1 ມື້ກ່ອນ
Grifols stock reports stronger first half with profit up 28.7%
Profile
Grifols, S.A. is a global healthcare company and leading producer of plasma-derived medicines founded in Barcelona, Catalonia, Spain, in 1909. With a workforce of over 23,800 employees, Grifols serves more than 110 countries and regions and maintains a direct presence in over 30.
Principally a producer of blood plasma–based products and other biopharmaceuticals, the company also operates in transfusion medicine, supplying devices, instruments and reagents for clinical testing laboratories, as well as clinical diagnostic technologies. Furthermore, it provides biological supplies for life-science research, clinical trials and the manufacturing of pharmaceutical and diagnostic products. It has a portfolio on four therapeutic areas: immunology, infectious diseases, pulmonology and critical care. Wikipedia
About Grifols SA Class A